Latest filing published 17 Jan 2025 for Adaptimmune Therapeutics PLC, €3,148.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Elliot Norry discloses dealings in Adaptimmune Therapeutics PLC to SEC (Form 4). Between 14 January 2020 and 17 January 2025, the trades on record add up to 21 filings.
On the market, this insider has only sold: 21 sales, €107k in total. In 2025 alone, the filings show no purchases and 4 sales.
On 17 January 2025 came the latest disclosure, an open-market sale for €3,148 in Adaptimmune Therapeutics PLC. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations